The Psychedelic Report
Exploring the Nexus of Sexuality, Health, and Longevity with Dr. Amy Killen
May 7, 2024 · 49 min
Why listen
Research links regular sexual activity to longer life, and this episode explains why that connection is real.
0:00––:––
Enjoy the episode?
Subscribe to The Psychedelic Report
Listen & subscribe on
In this episode
- How sexual activity affects mortality risk according to current research
- The role of dopamine, oxytocin, and other neurochemicals in sexual health
- Why self-exploration and communication are core health practices
- How healthcare can better address sexual well-being without stigma
About this episode
In this episode of The Psychedelic Report, Dr. Dave Rabin and Dr. Amy Killen delve into the profound correlation between sexuality, intimacy, and longevity. Dr. Killen, a physician, presents compelling research demonstrating that regular sexual activity is associated with reduced mortality rates, particularly in men, attributing this effect to the physiological impact of sexual experiences, including the release of neurotransmitters like dopamine, endorphins, serotonin, and oxytocin. They advocate for a comprehensive approach to sexual education, emphasizing self-exploration, effective communication, and the destigmatization of pleasure. This episode addresses societal taboos around sexuality and underscores the importance of prioritizing sexual health in healthcare practices. Overall, they challenge listeners to adopt a more open-minded and holistic perspective on sexuality, recognizing its profound impact on overall well-being and quality of life.- Web: https://dramykillen.com/
- Instagram:https://www.instagram.com/dr.amybkillen/
- Facebook: https://www.facebook.com/DrAmyBKillen/
- Twitter: https://twitter.com/DrDavidRabin
- Instagram: https://www.instagram.com/drdavidrabin
- Web: https://www.drdave.io/
- Web: www.ApolloNeuro.com
Learn more about your ad choices. Visit megaphone.fm/adchoices
About The Psychedelic Report
Dr. Dave Rabin MD, PhD, a psychiatrist and neuroscientist trained in Ketamine and MDMA-assisted therapy, brings you the newest developments from the world of psychedelic science and technology. From researchers and investors to physicians and shamans to nonprofit pioneers and policy-makers — each week, Dr.
See all episodes →
